Dyadic International, Inc. is a global biotechnology company focused on further improving and applying the proprietary C expression system to help drug developers and manufacturers bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties that will improve access and cost to patients and the healthcare system, but most importantly save lives.
Quote | Dyadic International Inc. (OTCMKTS:DYAI)
Last: | $ |
---|---|
Change Percent: | -3.17% |
Open: | $6.03 |
Close: | $5.80 |
High: | $6.10 |
Low: | $5.75 |
Volume: | 122,551 |
Last Trade Date Time: | 02/12/2020 04:55:12 pm |
News | Dyadic International Inc. (OTCMKTS:DYAI)
2024-04-24 17:36:16 ET More on Dyadic International Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript Dyadic's Michael Tarnok to step down as Chairman of the board of directors Dyadic announces strategic partnership agreement to develop rabies v...
2024-03-28 22:22:08 ET Dyadic International, Inc. (DYAI) Q4 2023 Earnings Conference Call March 28, 2024 05:00 PM ET Company Participants Mark Emalfarb - President, Chief Executive Officer Ping Rawson - Chief Financial Officer Joseph Hazelton - Chief Operating Of...
Message Board Posts | Dyadic International Inc. (OTCMKTS:DYAI)
Subject | By | Source | When |
---|---|---|---|
$DYAI where is the squeeze? | blue_skies | investorshub | 04/27/2023 7:53:41 PM |
Price now last up | natec22 | investorshub | 04/27/2023 11:11:40 AM |
$DYAI Price trading up | blue_skies | investorshub | 04/27/2023 8:33:31 AM |
best news of the day | blue_skies | investorshub | 04/27/2023 7:59:27 AM |
Price now last up | blue_skies | investorshub | 04/26/2023 9:11:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Dyadic International Inc. Company Name:
DYAI Stock Symbol:
OTCMKTS Market:
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrants Reported positive topline data from First-In-Human Phase 1 trial demonstrated clinical safety and antibod...
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a bi...
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins f...